Related Experiment Video
Updated: Oct 17, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Obesity treatment access in the United States: a state-level scorecard
John David Scott1, Allyson Lynn Hale2, Tracy Zvenyach3
1Division of Bariatric and Minimal Access Surgery, Department of Surgery, University of South Carolina School of Medicine, Greenville, South Carolina.
Background:
Obesity affects more than 40% of U.S. adults and carries substantial morbidity and mortality, yet access to evidence-based treatment varies widely across jurisdictions.
Objectives:
To evaluate and compare state-level access to evidence-based obesity treatment across the United States using a standardized composite framework.
Setting:
50 U.S. states and the District of Columbia (51 jurisdictions).
Methods:
Ecological cross-sectional study using publicly available policy and administrative data aggregated in 2026; the unit of analysis was the jurisdiction and no individual patient-level data were used. The Obesity Treatment Access Scorecard was derived from 44 metrics across 6 weighted tiers, coverage, access barriers, workforce capacity, regulatory factors, patient context, and treatment utilization, yielding scores of 0-100 mapped to letter grades (A-F). Data were verified by expert review with multisource validation, and sensitivity analyses tested alternative tier-weighting schemes.
Results:
Scores ranged from 25.5 to 77.7 (mean, 48.5; standard deviation [SD], 12.8). No state achieved an A grade (≥80). Fifteen jurisdictions (29.4%) scored below 40 and 10 (19.6%) scored 60 or higher. Massachusetts (77.7) and Minnesota (76.4) ranked the highest; Arkansas (25.5), Oklahoma (28.5), and West Virginia (28.9) ranked the lowest. Mean scores were highest in the Northeast (62.7 [SD, 10.2]) and lowest in the South (39.9 [SD, 10.5]). Variability was greatest in the patient context and workforce capacity tiers. Jurisdiction rankings were robust to alternative tier-weighting schemes (Spearman ρ ≥ .99).
Conclusions:
Access to evidence-based obesity treatment is highly variable across the United States, with no state achieving top performance. These findings highlight significant geographic disparities and support the need for policy and system-level reforms. The Obesity Treatment Access Scorecard is presented as an exploratory benchmarking framework requiring further validation before use in policy evaluation.
More Related Videos
08:01A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
Published on: August 12, 2016
06:55Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Related Concept Videos
Obesity
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Introduction To Health Care Delivery System
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion